Third Space Endoscopic Therapies for Benign Motility Disorders: A Narrative Review
DEN Open · 2027-04 · 7 (1)
DOI: 10.1002/deo2.70397 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift DEN Open, online erschienen am 12.08.2026. Verfasst von Sanjana Bhagwat und 1 weiteren Autor:innen. Beteiligte Einrichtung: Shivanand Desai Center for Digestive Disorders Deenanath Mangeshkar Hospital and Research Center Pune India. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
To review the evidence base, evolution, outcomes, adverse events (AEs), and management for third‐space endoscopy (TSE) procedures for management of benign motility disorders.
Methods
This review examines TSE procedures for motility disorders, reviewing the current available techniques, success, outcomes, and long‐term outcomes from the literature.
Results
Peroral endoscopic myotomy (POEM) for achalasia cardia is now established as first‐line therapy, endorsed by the American Society for Gastrointestinal Endoscopy, American College of Gastroenterology, Society of American Gastrointestinal and Endoscopic Surgeons, and international expert bodies, with long‐term clinical success exceeding 90% at 7 years. Since 2010, the technique has evolved considerably, with refinements in myotomy length, orientation, and depth, along with intraoperative use of an endoluminal functional lumen imaging probe to optimize outcomes and reduce post‐procedure gastroesophageal reflux (GER). The TSE platform has since expanded to spastic esophageal disorders, esophagogastric junction outflow obstruction, Zenker's and epiphrenic diverticula (Z‐POEM/D‐POEM), refractory gastroparesis (gastric per‐oral endoscopic pyloromyotomy), and Hirschsprung's disease. Techniques have also been modified along the way to achieve better results while minimizing AEs. Post‐POEM GER, occurring objectively in 40%–55% of patients, remains the principal long‐term challenge, and multiple modalities have been explored to address it.
Conclusions
TSE has fundamentally transformed the management of benign gastrointestinal motility disorders, with POEM serving as the paradigm for the shift from surgical to endoscopic treatment. Ongoing technical refinement, GER mitigation strategies, and emerging innovations are poised to further advance the field. Trial Registration N/A.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Shivanand Desai Center for Digestive Disorders Deenanath Mangeshkar Hospital and Research Center Pune India.
ORCID-Profile: Sanjana Bhagwat, Amol Bapaye
Zitieren
APA
Bhagwat, S., & Bapaye, A. (2027). Third Space Endoscopic Therapies for Benign Motility Disorders: A Narrative Review. DEN Open, 7(1). https://doi.org/10.1002/deo2.70397
Vancouver
Bhagwat S, Bapaye A. Third Space Endoscopic Therapies for Benign Motility Disorders: A Narrative Review. DEN Open. 2027;7(1). doi:10.1002/deo2.70397
BibTeX
@article{Bhagwat2027,
author = {Bhagwat, Sanjana and Bapaye, Amol},
title = {Third Space Endoscopic Therapies for Benign Motility Disorders: A Narrative Review},
journal = {DEN Open},
year = {2027},
volume = {7},
number = {1},
doi = {10.1002/deo2.70397}
}
EUVIMED